Feb 25, 2026 04:04PM
Feb 25, 2026 04:01PM
Feb 9, 2026 05:05PM
Nov 6, 2025 05:26PM
Nov 6, 2025 04:01PM
Oct 22, 2025 04:01PM
Aug 11, 2025 04:10PM Maravai LifeSciences (MRVI) Misses Q2 EPS by 1c, withdraws guidance
Aug 11, 2025 04:05PM
Aug 11, 2025 04:05PM
Jul 28, 2025 05:08PM
Jun 25, 2025 04:01PM
Jun 25, 2025 04:01PM
Jun 9, 2025 08:31AM
Jun 9, 2025 08:30AM Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
May 12, 2025 04:18PM
May 12, 2025 04:06PM
May 5, 2025 11:01AM
May 4, 2025 08:36PM
May 2, 2025 11:12AM
May 1, 2025 07:30AM
Apr 29, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
Apr 25, 2025 11:35AM
Apr 24, 2025 02:29PM
Apr 23, 2025 01:24PM
Apr 22, 2025 10:10AM
Apr 21, 2025 11:17AM
Apr 18, 2025 11:17AM
Apr 17, 2025 03:49PM Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action - Hagens Berman
Apr 17, 2025 10:15AM
Apr 14, 2025 09:38AM
Apr 12, 2025 09:30AM
Apr 10, 2025 08:37AM
Apr 8, 2025 04:08PM
Apr 7, 2025 08:00AM
Apr 3, 2025 01:55PM Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending - Hagens Berman
Apr 3, 2025 08:00AM
Apr 1, 2025 07:33PM
Mar 30, 2025 08:00AM
Mar 27, 2025 05:01PM
Mar 26, 2025 12:20PM
Mar 26, 2025 08:00AM
Mar 20, 2025 04:29PM Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition - Hagens Berman
Mar 18, 2025 07:43PM
Mar 18, 2025 04:08PM
Mar 18, 2025 04:05PM
Mar 18, 2025 07:20AM
Mar 14, 2025 11:40AM
Mar 12, 2025 05:48PM
Mar 9, 2025 11:15AM MRVI INVESTOR NOTICE: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Feb 26, 2025 10:29AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All